MOBILion Systems, Inc.
Exton, US · Founded 2015 · Delaware corporation · 3 known investors
MOBILion develops separation science instrumentation designed for accurate, high-throughput analysis with enhanced resolution and reproducibility. Its tools serve the diagnostic, healthcare, food, and environmental safety research markets.
Founders & leadership
MA
MICHAEL ALBINDirector
JL
JUDIT LOSONCZIDirector
HD
HEINER DREISMANNDirector
MS
MELISSA SHERMANExecutive Officer, Director
JS
JASON SMITHDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$60MraisedJul 2021 · 7 investors · BiotechnologyRule 506(b)
▶$60MraisedJul 2021 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MELISSA SHERMANExecutive Officer, Director
- TAD WEEMSDirector
- JASON SMITHDirector
- HEINER DREISSMANDirector
- TODD SONEDirector
- MICHAEL ALBINDirector
- CRAIG CARRAExecutive Officer
- Offering amount
- $60M
- Amount sold
- $60M
- Proceeds to insiders
- $4M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$35.1MraisedAug 2020 · 7 investors · BiotechnologyRule 506(b)
▶$35.1MraisedAug 2020 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- TODD SONEDirector
- JASON SMITHDirector
- HEINER DREISSMANDirector
- MICHAEL ALBINDirector
- TAD WEEMSDirector
- MELISSA SHERMANExecutive Officer, Director
- Offering amount
- $35.1M
- Amount sold
- $35.1M
- Minimum investment
- $250K
- Proceeds to insiders
- $1.5M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$6MraisedMay 2020 · 1 investors · BiotechnologyRule 506(b)
▶$6MraisedMay 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Melissa ShermanExecutive Officer, Director
- Heiner DreissmanDirector
- Jason SmithDirector
- Alan AubreyDirector
- Tad WeemsDirector
- Michael AlbinDirector
- Offering amount
- $6M
- Amount sold
- $6M
- Minimum investment
- $6M
- Proceeds to insiders
- $250K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$4MraisedApr 2019 · 2 investors · BiotechnologyRule 506(b)
▶$4MraisedApr 2019 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MICHAEL ALBINDirector
- JUDIT LOSONCZIDirector
- HEINER DREISMANNDirector
- MELISSA SHERMANExecutive Officer, Director
- JASON SMITHDirector
- Offering amount
- $10M
- Amount sold
- $4M
- Minimum investment
- $3
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.